GenOway Sues Cellectis Over Knock-in IP | GenomeWeb

NEW YORK (GenomeWeb News) — GenOway has sued Cellectis for allegedly breaching a license agreement for recombinant gene-targeting technology by attempting to forge similar license deals with GenoWay's clients directly, GenOway said today.

The company said it has asked for "several million euros" in compensation, but did not provide further financial details of the suit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.